Cell & Gene Therapy Manufacturing Services Market 2026–2030: Forecasting Business Opportunities Ahead
Uncover key drivers, emerging technologies, and competitive movements shaping the cell & gene therapy manufacturing services market from 2026–2035 with trusted insights from The Business Research Company
What level of growth is expected in the Cell & Gene Therapy Manufacturing Services Market between 2026 and 2030?
The cell & gene therapy manufacturing services market size has witnessed swift growth over recent years. It is anticipated to expand from $9.44 billion in 2025 to $11.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.4%. This historical growth can be ascribed to an increasing volume of cell and gene therapy clinical candidates, the early outsourcing of manufacturing services, the expansion of academic translational research, limitations in in-house manufacturing capabilities, and a rising demand for specialized bioprocessing.
The cell & gene therapy manufacturing services market size is projected to experience swift expansion over the coming years. This market is set to reach $21.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. Several factors contribute to this anticipated growth during the forecast period, such as the increasing commercialization of cell and gene therapies, a heightened need for extensive manufacturing services, the broadening of personalized medicine pipelines, greater regulatory clarity for advanced therapies, and increased investments in advanced therapy infrastructure. Key trends expected in the forecast period encompass the enlargement of GMP-compliant manufacturing capacity, the wider uptake of automated cell processing systems, a growing requirement for scalable viral vector production, the increased incorporation of advanced quality control technologies, and an intensified emphasis on manufacturing standardization.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10035&type=smp
Which Drivers Are Expected To Impact The Cell & Gene Therapy Manufacturing Services Market During The Forecast Period?
The prevalence of cancer and other specific ailments is anticipated to drive expansion within the cell and gene therapy manufacturing services market moving forward. Cancer is a grave condition characterized by the rapid and unrestrained multiplication of the body’s cells, leading to irregular formations. Cell and gene therapies are emerging as hopeful new approaches to address the increasing prevalence of cancer, thereby fueling the need for innovative and effective therapeutic options. For example, as reported by the American Cancer Society, a US-based nonprofit cancer advocacy organization, in February 2025, projections indicate that in the US in 2025, there will be an estimated 316,950 new cases of invasive breast cancer diagnosed in women and 2,800 cases in men. Consequently, the widespread occurrence of cancer and other target diseases is propelling the expansion of the cell and gene therapy manufacturing services market going forward.
How Is The Cell & Gene Therapy Manufacturing Services Market Divided Into Segments?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
Which Trends Are Expected To Influence The Cell & Gene Therapy Manufacturing Services Market In The Upcoming Years?
Leading firms within the cell and gene therapy manufacturing services market are concentrating on creating advanced biomanufacturing techniques to boost the scalability, output effectiveness, and general standard of cell and gene therapies. As an example, in September 2025, ARPA-H, a US-based government health agency, initiated a new program designed to stimulate groundbreaking biomanufacturing for cell and gene therapies. This initiative seeks to speed up the creation of sophisticated manufacturing platforms, elevate production outputs, and facilitate the affordable, scalable production of intricate cell and gene therapy products. Through its backing of high-risk, high-reward technologies, this undertaking is anticipated to spur innovation in biomanufacturing, fortify the manufacturing environment, and expedite patients’ access to life-changing treatments.
Which Major Firms Are Strengthening Their Position In The Cell & Gene Therapy Manufacturing Services Market?
Major companies operating in the cell & gene therapy manufacturing services market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Fujifilm Holdings Corporation, Oxford Biomedica plc, Cell and Gene Therapy Catapult, Samsung Biologics Co. Ltd., BioNTech SE, Novartis International AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Sarepta Therapeutics Inc., bluebird bio Inc., Precision BioSciences Inc., GSK plc, AstraZeneca plc, Bayer AG
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Cell & Gene Therapy Manufacturing Services Market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cell & Gene Therapy Manufacturing Services Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10035&type=smp
Browse Through More Reports Similar to the Global Cell & Gene Therapy Manufacturing Services Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
